Experience with OKT3 after orthotopic liver transplantation.
Stratta
R
R
Department of Surgery, University of Nebraska School of Medicine, Omaha.
Shaefer
M
M
Bradshaw
K
K
Wood
R
R
Langnas
A
A
Zetterman
R
R
Donovan
J
J
Sorrell
M
M
Markin
R
R
Shaw
B W
BW
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000945:Antigens, Differentiation, T-Lymphocyte / Q000032:analysis; D017252:CD3 Complex; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D016031:Liver Transplantation / Q000379:methods*; D016853:Muromonab-CD3; D011446:Prospective Studies; D011948:Receptors, Antigen, T-Cell / Q000032:analysis; D016176:T-Lymphocyte Subsets / Q000276:immunology
D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte; D017252:CD3 Complex; D016853:Muromonab-CD3; D011948:Receptors, Antigen, T-Cell